BCL2 Expression Correlates With Surface Immunoglobulin Levels and Prognosis in Follicular Lymphoma Patients

被引：0
|
作者：
Barreca, A.
Martinengo, C. [1 ]
Righi, L. [2 ]
Chiappella, A. [3 ]
Ladetto, M. [4 ]
Chiusa, L. [3 ]
Stacchini, A. [3 ]
Chiarle, R. [1 ]
机构：
[1] Univ Turin, Dept Biomed Sci & Human Oncol, Ctr Expt Med & Clin Studies Cerms, I-10124 Turin, Italy
[2] Univ Turin, S Luigi Hosp, Dept Clin & Biol Sci, Div Pathol, Orbassano, Italy
[3] ASO San Giovanni Battista Hosp, Dept Biomed Sci & Human Oncol, Turin, Italy
[4] Univ Turin, Dept Expt Med & Oncol, Turin, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72500-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S649 / S649
页数：1
相关论文
共 50 条
  • [1] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    A Barreca
    C Martinengo
    L Annaratone
    L Righi
    A Chiappella
    M Ladetto
    A Demurtas
    L Chiusa
    A Stacchini
    N Crosetto
    A van Oudenaarden
    R Chiarle
    Blood Cancer Journal, 2014, 4 : e249 - e249
  • [2] Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
    Barreca, A.
    Martinengo, C.
    Annaratone, L.
    Righi, L.
    Chiappella, A.
    Ladetto, M.
    Demurtas, A.
    Chiusa, L.
    Stacchini, A.
    Crosetto, N.
    van Oudenaarden, A.
    Chiarle, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e249 - e249
  • [3] BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
    Huet, Sarah
    Szafer-Glusman, Edith
    Tesson, Bruno
    Xerri, Luc
    Fairbrother, Wayne J.
    Mukhyala, Kiran
    Bolen, Chris
    Punnoose, Elizabeth
    Tonon, Laurie
    Chassagne-Clement, Catherine
    Feugier, Pierre
    Viari, Alain
    Jardin, Fabrice
    Salles, Gilles
    Sujobert, Pierre
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (06) : 515 - 519
  • [4] BCL2 in follicular lymphoma: the overrated guy?
    Magnoli, F.
    Amaglio, C.
    Marchiori, D.
    Vivian, L. F.
    Martin, V.
    Sessa, F.
    Tibiletti, M. G.
    Uccella, S.
    VIRCHOWS ARCHIV, 2019, 475 : S116 - S117
  • [5] Detection of BCL2 rearrangements in follicular lymphoma
    Aster, JC
    Longtine, JA
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03): : 759 - 763
  • [6] BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma
    Uppal, G.
    Wang, Z-X
    Bajaj, R.
    Curtis, M.
    Solomides, C. C.
    Glass, J.
    Banks, P.
    Peiper, S. C.
    Gong, J. Z.
    LABORATORY INVESTIGATION, 2014, 94 : 383A - 383A
  • [7] BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma
    Uppal, G.
    Wang, Z-X
    Bajaj, R.
    Curtis, M.
    Solomides, C. C.
    Glass, J.
    Banks, P.
    Peiper, S. C.
    Gong, J. Z.
    MODERN PATHOLOGY, 2014, 27 : 383A - 383A
  • [8] Translocation of BCL2 and BCL6 to the same immunoglobulin heavy chain locus in a case of Follicular Lymphoma
    Rack, K
    Delannoy, A
    Ravoet, C
    Vannuffel, P
    Hamels, J
    Gillerot, Y
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1513 - 1516
  • [9] Grade, BCL2 gene abnormality and expression, and clinical relevance in follicular lymphoma
    Goodlad, JR
    Batstone, PJ
    Hamilton, D
    Forsyth, L
    Sales, MJ
    Pratt, NR
    Kernohan, NM
    Levison, DA
    White, JM
    JOURNAL OF PATHOLOGY, 2005, 207 : 10 - 10
  • [10] BCL2 GENE ACTIVATION AND PROTEIN EXPRESSION IN FOLLICULAR LYMPHOMA - A REPORT ON 64 CASES
    SEITE, P
    HILLION, J
    DAGAY, MF
    GAULARD, P
    CAZALS, D
    BADOUX, F
    BERGER, R
    LARSEN, CJ
    LEUKEMIA, 1993, 7 (03) : 410 - 417
12345